XML 33 R21.htm IDEA: XBRL DOCUMENT

Equity	9 Months Ended
Equity	Sep. 30, 2025
Equity [Abstract]
Equity	Equity On December 2, 2020, we announced that our Board of Directors authorized a $100 million share repurchase program, with no set expiration or termination date. Our repurchase program does not obligate us to acquire any particular common stock amount. The program grants management discretion to determine the timing and amount of any share repurchases under the authorization based on market conditions and other considerations. In Nine Months 2025, we repurchased 698,312 shares of our common stock under the program. The cost of these repurchases was $55.6 million, including commissions. Authorized repurchases reflected in the Consolidated Statement of Stockholders' equity also included estimated excise tax of $0.3 million in Nine Months 2025. We had $19.9 million of remaining program capacity as of September 30, 2025. On October 22, 2025, the Company announced that its Board of Directors authorized a new share repurchase program under which the Company may repurchase issued and outstanding shares of common stock up to $200 million, exclusive of any excise tax impact. This program is effective on October 27, 2025 and has no expiration date. The Company’s existing share repurchase program remained effective through October 24, 2025.